Start for free
Start for free
MI

Maven Investment Partners US

Asia, Dubai, United Arab Emirates, Dubai

Description

Maven Investment Partners is an advisory firm engaging in corporate finance advisory, M&A, crisis management, and governance initiatives.

Investor Profile

Maven Investment Partners US has made 6 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (67%)
  • Series Unknown (17%)
  • Post Ipo Secondary (17%)

Country Focus

  • United States (67%)
  • Canada (17%)
  • Sweden (17%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Biopharma
  • Wellness
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Maven Investment Partners US frequently co-invest with?

Altium Capital
Altium Capital
North America, New York, United States, New York
Co-Investments: 1
Adage Capital Management
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
DC
Driehaus Capital Management
North America, Illinois, United States, Chicago
Co-Investments: 2
Woodline Partners
Woodline Partners
North America, California, United States, San Francisco
Co-Investments: 2
Braidwell
Braidwell
North America, Connecticut, United States, Stamford
Co-Investments: 2
Sphera Global Healthcare Fund
Sphera Global Healthcare Fund
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 2
Ikarian Capital
Ikarian Capital
North America, Texas, United States, Dallas
Co-Investments: 1
Redmile Group
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 3
Invus
Invus
North America, New York, United States, New York
Co-Investments: 1
Fidelity
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 1

What are some of recent deals done by Maven Investment Partners US?

Hansa Biopharma

Lund, Skane Lan, Sweden

Hansa Biopharma is a biopharmaceutical company that develops immunomodulatory treatments for people living with rare immunological diseases.

BiotechnologyHealth Care
Post Ipo EquityApr 12, 2024
Amount Raised: $34,222,770
Ventyx Biosciences

Encinitas, California, United States

Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.

BiopharmaBiotechnology
Post Ipo EquitySep 19, 2022
Amount Raised: $176,600,000
Aileron Therapeutics

Cambridge, Massachusetts, United States

Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides.

BiopharmaBiotechnologyTherapeutics
Post Ipo SecondaryJan 6, 2021
Amount Raised: $35,900,000
Kineta (Reverse Merger With Yumanity Therapeutics)

Boston, Massachusetts, United States

Yumanity Therapeutics is a biotechnology company that transforms drug discovery for diseases caused by protein misfolding.

BiotechnologyHealth CareTherapeutics
Series UnknownDec 15, 2020
Amount Raised: $33,599,895
MedAvail

Mississauga, Ontario, Canada

MedAvail focuses on the discovery, development, and commercialization of advanced nutrition products.

BiotechnologyHealth CareMedicalWellness
Post Ipo EquityNov 25, 2020
Amount Raised: $96,991,275
Frequency Therapeutics

Lexington, Massachusetts, United States

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.

BiotechnologyGeneticsHealth CareMedical
Post Ipo EquityJul 17, 2020
Amount Raised: $42,300,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator